Health Insurance Innovations (HIIQ) – Research Analysts’ Weekly Ratings Changes

Health Insurance Innovations (NASDAQ: HIIQ) recently received a number of ratings updates from brokerages and research firms:

  • 2/13/2018 – Health Insurance Innovations is now covered by analysts at B. Riley. They set a “buy” rating and a $38.00 price target on the stock.
  • 2/13/2018 – Health Insurance Innovations was downgraded by analysts at Zacks Investment Research from a “buy” rating to a “hold” rating. According to Zacks, “Health Insurance Innovations, Inc. operates as a developer and administrator of web-based individual health insurance plans and ancillary products. Its product portfolio consists of short-term medical plans, accident, sickness & hospital medical plans, ancillary insurance, life insurance, lifestyle and discount services. Health Insurance Innovations, Inc. is based in Tampa, Florida. “
  • 2/10/2018 – Health Insurance Innovations was downgraded by analysts at BidaskClub from a “buy” rating to a “hold” rating.
  • 2/8/2018 – Health Insurance Innovations was downgraded by analysts at ValuEngine from a “buy” rating to a “hold” rating.
  • 2/2/2018 – Health Insurance Innovations was upgraded by analysts at ValuEngine from a “hold” rating to a “buy” rating.
  • 1/25/2018 – Health Insurance Innovations was upgraded by analysts at Zacks Investment Research from a “hold” rating to a “buy” rating. They now have a $31.00 price target on the stock. According to Zacks, “Health Insurance Innovations, Inc. operates as a developer and administrator of web-based individual health insurance plans and ancillary products. Its product portfolio consists of short-term medical plans, accident, sickness & hospital medical plans, ancillary insurance, life insurance, lifestyle and discount services. Health Insurance Innovations, Inc. is based in Tampa, Florida. “
  • 1/23/2018 – Health Insurance Innovations was upgraded by analysts at BidaskClub from a “hold” rating to a “buy” rating.
  • 1/17/2018 – Health Insurance Innovations was upgraded by analysts at Zacks Investment Research from a “sell” rating to a “hold” rating. According to Zacks, “Health Insurance Innovations, Inc. operates as a developer and administrator of web-based individual health insurance plans and ancillary products. Its product portfolio consists of short-term medical plans, accident, sickness & hospital medical plans, ancillary insurance, life insurance, lifestyle and discount services. Health Insurance Innovations, Inc. is based in Tampa, Florida. “
  • 1/3/2018 – Health Insurance Innovations was downgraded by analysts at ValuEngine from a “buy” rating to a “hold” rating.
  • 12/22/2017 – Health Insurance Innovations had its “buy” rating reaffirmed by analysts at Canaccord Genuity. They now have a $39.00 price target on the stock. They wrote, “We reiterate our BUY rating and $39 PT. Issued today, (preliminary) final ACA enrollment figures at 8.8M fell ~400K short of last year, which is more than some experts expected given the headwinds the enrollment process faced this year. However, we maintain our view that it is difficult to gauge how the ACA enrollment levels (vs. last year) will impact HIIQ. On another note, the tax bill will repeal the individual mandate in 2019, which we explain below should be positive for demand for HIIQ’s offering. We remain bullish on HIIQ and believe that the longer-term outlook remains favorable.””

Shares of Health Insurance Innovations Inc (NASDAQ:HIIQ) opened at $24.65 on Wednesday. Health Insurance Innovations Inc has a 52 week low of $12.65 and a 52 week high of $37.38. The firm has a market capitalization of $407.78, a P/E ratio of 20.20 and a beta of 0.62.

In other news, Director Robert S. Murley acquired 5,000 shares of Health Insurance Innovations stock in a transaction on Friday, December 8th. The stock was bought at an average price of $22.50 per share, for a total transaction of $112,500.00. Following the completion of the purchase, the director now owns 39,734 shares in the company, valued at $894,015. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CTO Sheldon Wang sold 1,232 shares of the business’s stock in a transaction that occurred on Thursday, December 28th. The shares were sold at an average price of $25.00, for a total value of $30,800.00. Following the completion of the sale, the chief technology officer now owns 137,769 shares of the company’s stock, valued at approximately $3,444,225. The disclosure for this sale can be found here. In the last quarter, insiders sold 62,464 shares of company stock valued at $1,605,100. 30.00% of the stock is owned by company insiders.

Health Insurance Innovations, Inc is a developer, distributor and cloud-based administrator of individual and family health insurance plans (IFPs) and supplemental products, which include short-term medical (STM) insurance plans, and guaranteed-issue and underwritten hospital indemnity plans. The Company also develops, distributes and administers supplemental products, which include a range of additional insurance and non-insurance products, such as pharmacy benefit cards, dental plans, vision plans, cancer/critical illness plans, deductible and gap protection plans, and life insurance policies that are purchased as supplements to IFP.

Receive News & Ratings for Health Insurance Innovations Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Health Insurance Innovations Inc and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply